Cardiorenal protection by subcutaneous cenderitide in experimental heart failure: a novel and safe therapeutic for humans with LVAD support
28 August 2018 (14:00 - 18:00)
Organised by:
Abstract
About the speaker
Mayo Clinic, Rochester (United States of America)
8 More presentations in this session
Access the full session
The Event
ESC Congress 2018
28 August 2018
14:00 CET
You may be interested in
Congress Presentation
